ANO10 and prostate cancer: One of the key observations made in our analysis was much lower expression of ANO1, ANO8 and ANO10 in LNCap low-metastatic and DU145 moderately-metastatic cells when compared to PC3 highly-metastatic prostate cancer cells (Fig. 1A).